| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575 |
| filingDate |
1986-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1989-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0225109-A3 |
| titleOfInvention |
Vasopressin antagonists |
| abstract |
Peptides having vasopressin antagonist activity nare prepared by a peptide synthesizer to insert a N-methyl narginine at the 7-position of the structure. n nAn example nof this series of compounds is [1-(β-mercapto-β,β-cyclo-npentamethylenepropionic acid)-2-(O-ethyl-D-tyrosine) -4-nvaline-7-depresoline-8-N-methylarginine-9-desglycine]-nvasopressin. |
| priorityDate |
1985-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |